Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China · Delayed Price · Currency is CNY 9.60
-0.12 (-1.23%)
At close: Feb 13, 2026
SHA:603229 Market Cap
SHA:603229 has a market cap or net worth of 7.95 billion as of February 13, 2026. Its market cap has increased by 10.97% in one year.
Market Cap
7.95B
Enterprise Value
7.19B
Revenue
751.12M
Ranking
n/a
PE Ratio
43.36
Stock Price
9.60
Market Cap Chart
Since May 9, 2017, SHA:603229's market cap has increased from 1.80B to 7.95B, an increase of 341.76%. That is a compound annual growth rate of 18.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 7.95B | -3.23% |
| Dec 31, 2025 | 8.22B | -0.94% |
| Dec 31, 2024 | 8.29B | 5.87% |
| Dec 29, 2023 | 7.83B | -18.09% |
| Dec 30, 2022 | 9.56B | -8.49% |
| Dec 31, 2021 | 10.45B | 19.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sino Biological,Inc. | 8.91B |
| Daan Gene | 8.84B |
| Jiangxi Fushine Pharmaceutical | 8.82B |
| Shanghai Medicilon | 8.74B |
| Anhui Huaheng Biotechnology | 8.55B |
| Acrobiosystems | 8.35B |
| Nanjing Vazyme Biotech | 8.26B |
| Suzhou Fengbei Biotech Stock | 7.86B |